Issued Patents All Time
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12427125 | Method for treating SARS and treating or preventing ARDS | — | 2025-09-30 |
| 12384852 | Genetically modified NK-92 cells having a safety switch | Hans G. Klingemann, Barry J. Simon, Laurent H. Boissel, Kerry S. Campbell | 2025-08-12 |
| 12268660 | Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension | Zhenhuan Zheng | 2025-04-08 |
| 12201593 | Oral pharmaceutical formulations of bitter compounds for asthma | Zhenhuan Zheng | 2025-01-21 |
| 11788059 | Modified NK-92 cells for treating cancer | — | 2023-10-17 |
| 11207350 | Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer | Hans G. Klingemann, Barry J. Simon, Laurent H. Boissel | 2021-12-28 |
| 11110127 | Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders | — | 2021-09-07 |
| 11000550 | Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer | Hans G. Klingemann, Barry J. Simon, Laurent H. Boissel | 2021-05-11 |
| 10835505 | Oral pharmaceutical formulation for weight loss, diabetes and related disorders | — | 2020-11-17 |
| 10738279 | Modified NK-92 cells for treating cancer | — | 2020-08-11 |
| 10736921 | Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer | Hans G. Klingemann, Barry J. Simon, Laurent H. Boissel | 2020-08-11 |
| 10456420 | Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer | Hans G. Klingemann, Barry J. Simon, Laurent H. Boissel | 2019-10-29 |
| 10434070 | Use of nanoparticles coated with red blood cell membranes to enable blood transfusion | — | 2019-10-08 |
| 6232113 | Particle bombardment device | — | 2001-05-15 |